patent/EP-3360550-A1

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fc1c6e8a6c63bc5df73dc3028deb19ef
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-00
filingDate	2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4cef30cd402c3a6ad27705825460684f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d24072a686d52d41e96d1e7058f3cffd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4c7460b16e23bc2311c8ee73de3c253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63673da01927f5101aadaeabb249495f
publicationDate	2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	EP-3360550-A1
titleOfInvention	Molecules and pharmaceutical compositions, in particular for treating a genetic blood disorder
abstract	The present invention relates to molecules having the chemical structure (I) or a salt thereof for use in a method of therapeutic treatment of a mammal or in pharmaceutical compositions:n nwherein R1 to R13 are each independently an atom or a chemical group of atoms, n is 1, 2, 3, 4 or 5.
priorityDate	2017-02-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466869718 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466201124

Total number of triples: 18.